Swisspartners Ltd. Abb Vie Inc. Transaction History

Swisspartners Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$137.62 - $174.96 $177,529 - $225,698	-1,290 Closed	0 $0
Q1 2022 May 11, 2022	SELL	$131.98 - $163.75 $4.58 Million - $5.68 Million	-34,710 Reduced 96.42%	1,290 $209,000
Q1 2022 May 04, 2022	BUY	$131.98 - $163.75 $4.75 Million - $5.9 Million	36,000 New	36,000 $459,000
Q2 2021 Aug 11, 2021	SELL	$105.21 - $117.21 $247,243 - $275,443	-2,350 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$80.49 - $108.67 $189,151 - $255,374	2,350 New	2,350 $251,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Swisspartners Ltd., based on Form 13F filings with the SEC.

Stay updated on Swisspartners Ltd. with notifications on news.